Sentra PM (a Medical Food) and Trazodone in the Management of Sleep Disorders.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S9381
- By:
- Publication type:
- Article
Works matching IS 11795735 AND DT 2012
Results: 24
1
2
Vitamin K Antagonist Warfarin for Palliative Treatment of Metachromatic Leukodystrophy, A Compassionate Study of Four Subjects.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S9355
- By:
- Publication type:
- Article
3
Review of the Treatment of Restless Legs Syndrome: Focus on Gabapentin Enacarbil.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S9107
- By:
- Publication type:
- Article
4
Triggers for Autism: Genetic and Environmental Factors.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S9058
- By:
- Publication type:
- Article
5
Preventive Agents for Migraine: Focus on the Antiepileptic Drugs.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S9049
- By:
- Publication type:
- Article
6
Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S8755
- By:
- Publication type:
- Article
7
Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S8315
- By:
- Publication type:
- Article
8
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S6692
- By:
- Publication type:
- Article
9
Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S5128
- By:
- Publication type:
- Article
10
The Safety and Tolerability of Newer Antiepileptic Drugs in Children and Adolescents.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S5097
- By:
- Publication type:
- Article
11
Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists.
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S4103
- By:
- Publication type:
- Article
12
Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is there an odd one Out?
- Published in:
- Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S10150
- By:
- Publication type:
- Article
13
Sentra PM (a Medical Food) and Trazodone in the Management of Sleep Disorders.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 65, doi. 10.4137/JCNSD.S9381
- By:
- Publication type:
- Article
14
Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 105, doi. 10.4137/JCNSD.S8315
- By:
- Publication type:
- Article
15
Approved Beta Interferons in Relapsing-Remitting Multiple sclerosis: Is There an Odd One Out?
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 135, doi. 10.4137/JCNSD.S10150
- By:
- Publication type:
- Article
16
Review of the Treatment of Restless Legs Syndrome: Focus on Gabapentin Enacarbil.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 147, doi. 10.4137/JCNSD.S9107
- By:
- Publication type:
- Article
17
Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 117, doi. 10.4137/JCNSD.S8755
- By:
- Publication type:
- Article
18
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 81, doi. 10.4137/JCNSD.S6692
- By:
- Publication type:
- Article
19
Vitamin K Antagonist Warfarin for Palliative Treatment of Metachromatic Leukodystrophy, A Compassionate Study of Four Subjects.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 73, doi. 10.4137/JCNSD.S9355
- By:
- Publication type:
- Article
20
The Safety and Tolerability of Newer Antiepileptic Drugs in Children and Adolescents.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 51, doi. 10.4137/JCNSD.S5097
- By:
- Publication type:
- Article
21
Preventive Agents for Migraine: Focus on the Antiepileptic Drugs.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 37, doi. 10.4137/JCNSD.S9049
- By:
- Publication type:
- Article
22
Triggers for Autism: Genetic and Environmental Factors.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 27, doi. 10.4137/JCNSD.S9058
- By:
- Publication type:
- Article
23
Current and merging Therapies for the Treatment of Multiple clerosis: Focus on ladribine.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 1, doi. 10.4137/JCNSD.S5128
- By:
- Publication type:
- Article
24
Mood Disorders, ircadian Rhythms, Melatonin and Melatonin Agonists.
- Published in:
- Journal of Central Nervous System Disease, 2012, n. 4, p. 15, doi. 10.4137/JCNSD.S4103
- By:
- Publication type:
- Article